Large animal model of functional tricuspid regurgitation in pacing induced end-stage heart failure

被引:18
|
作者
Malinowski, Marcin [1 ,2 ]
Proudfoot, Alistair G. [1 ]
Langholz, David [1 ]
Eberhart, Lenora [1 ]
Brown, Michael [1 ]
Schubert, Hans [1 ]
Wodarek, Jeremy [1 ]
Timek, Tomasz A. [1 ]
机构
[1] Spectrum Hlth, Meijer Heart & Vasc Inst, 100 Michigan Ave SE, Grand Rapids, MI 49503 USA
[2] Med Univ Silesia, Sch Med Katowice, Dept Cardiac Surg, Katowice, Poland
关键词
Tricuspid regurgitation; Heart failure; Cardiomyopathy; VENTRICULAR ASSIST DEVICE; TACHYCARDIA-INDUCED CARDIOMYOPATHY; VALVE SURGERY; IMPLANTATION; IMPACT; GEOMETRY; TIME; PATHOGENESIS; PREDICTORS; OUTCOMES;
D O I
10.1093/icvts/ivx012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Functional tricuspid regurgitation (FTR) is common in patients with advanced heart failure and frequently complicates left ventricular assist device implantation yet remains poorly understood. We set out to establish large animal model of FTR that could serve as a research platform to investigate the pathogenesis of FTR associated with end-stage heart failure. METHODS: Through right thoracotomy, ten adult sheep underwent implantation of pacemaker with epicardial LV lead, five sonomicrometry crystals on the right ventricle, and left and right ventricular telemetry pressure sensors during a beating heart off-pump procedure. After 5 +/- 1 days of recovery, baseline haemodynamic, echocardiographic and sonomicrometry data were collected. Animals were paced thereafter at a rate of 220-240 beats/min until the development of heart failure and concomitant tricuspid regurgitation. RESULTS: Three animals died during early recovery period and one during the pacing phase. Six surviving animals were paced for a mean of 14 +/- 5 days. Cardiac function was significantly depressed compared to baseline, with LV ejection fraction falling from 69 +/- 2% to 22 +/- 4% (P < 0.001) and RV fractional area change from 52 +/- 11% to 25 +/- 9% (P = 0.005). All animals developed significant enlargement of tricuspid annulus (from 29.5 +/- 1.6 to 36.5 +/- 4.5 mm; P = 0.01) and right ventricle (from 21.9 +/- 0.2 to 30.3 +/- 0.6 mm; P = 0.03). Sonomicrometry derived contractility of RV free wall was depressed and at least moderate tricuspid insufficiency developed in all animals. CONCLUSIONS: Biventricular dysfunction, tricuspid annular dilatation and significant FTR were observed in our model of ovine tachycardia induced cardiomyopathy. This animal model reflects the clinical situation of end-stage heart failure patients presenting for mechanical support.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 50 条
  • [1] Large animal model of acute right ventricular failure with functional tricuspid regurgitation
    Malinowski, Marcin
    Proudfoot, Alistair G.
    Eberhart, Lenora
    Schubert, Hans
    Wodarek, Jeremy
    Langholz, David
    Rausch, Manuel K.
    Timek, Tomasz A.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 124 - 129
  • [2] Role of Cardiologists in the Management of Patients at End-stage Heart Failure With Functional Mitral Regurgitation
    Sakata, Yasushi
    Mizote, Isamu
    Asano, Yoshihiro
    Komuro, Issei
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S137 - S137
  • [3] Percutaneous Mitral Valve Repair for Functional Mitral Regurgitation with End-Stage Heart Failure
    Mizutani, Yukiko
    Kubo, Shunsuke
    Moody, Makar
    Nakamura, Mamoo
    Shiota, Takahiro
    Siegel, Robert
    Trento, Alfredo
    Kar, Saibal
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S157 - S157
  • [4] Multisite pacing for end-stage heart failure: Early experience
    Cazeau, S
    Ritter, P
    Lazarus, A
    Gras, D
    Backdach, H
    Mundler, O
    Mugica, J
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (11): : 1748 - 1757
  • [5] Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function
    Bakker P.F.
    Meijburg H.W.
    De Vries J.W.
    Mower M.M.
    Thomas A.C.
    Hull M.L.
    Robles De Medina E.O.
    Bredée J.J.
    [J]. Journal of Interventional Cardiac Electrophysiology, 2000, 4 (2) : 395 - 404
  • [6] Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function
    Bakker, PF
    Meijburg, HW
    de Vries, JW
    Mower, MM
    Thomas, AC
    Hull, ML
    de Medina, OR
    Bredée, JJ
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2000, 4 (02) : 395 - 404
  • [7] Mitral valve stiffening in end-stage heart failure: Evidence of an organic contribution to functional mitral regurgitation
    Grande-Allen, KJ
    Barber, JE
    Klatka, KM
    Houghtaling, PL
    Vesely, I
    Moravec, CS
    McCarthy, PM
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (03): : 783 - 790
  • [8] Pacemaker lead associated tricuspid regurgitation: Implications for pacing in heart failure
    Papp, MA
    Woods, TD
    Roth, JA
    Ezri, M
    Malhotra, A
    Siegel, R
    Cinquegrani, MP
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S66 - S66
  • [9] Levosimendan in End-Stage Heart Failure
    Yeo, Poh Shuan Daniel
    [J]. JACC-HEART FAILURE, 2013, 1 (04) : 365 - 365
  • [10] ICDs in end-stage heart failure
    Pettit, Stephen J.
    Browne, Susan
    Hogg, Karen J.
    Connelly, Derek T.
    Gardner, Roy S.
    May, Carl R.
    Macleod, Una
    Mair, Frances S.
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2012, 2 (02) : 94 - 97